NOTICES
Keystone Health Plan Central; Prescription Drug Rates; Rate Filing
[34 Pa.B. 3210] Keystone Health Plan Central requests, with filing no. 04-C, approval to revise its prescription drug rates with proposed effective dates of October 1, 2004, through December 31, 2005.
The requested rate changes range from 8.24% to 61.11% based on the plan, region and quarter.
With this filing, Keystone Health Plan Central will combine its three service areas into one and make other changes to make a seamless offering of the HMO product with other Capital Blue Cross products. In addition, age/sex rating would be applied to the drug program. These factors would be different from the base rates age/sex factors.
The filing will impact approximately 70,000 members and generate additional revenue amounting to $9.6 million annually.
A copy of the filing is available on the Insurance Department's (Department) website: www.ins.state.pa.us. To access the filing, select ''Consumer Information'' on the left side. Under ''General Information,'' click on ''Notices.'' The pdf copy is at the ''Filing.pdf'' link following the name of the filing.
Copies of the filing are available for public inspection during normal working hours, by appointment, at the Department's regional office in Harrisburg.
Interested parties are invited to submit written comments, suggestions or objections to Rashmi Mathur, Actuary, Bureau of Accident and Health Insurance, Insurance Department, 1311 Strawberry Square, Harrisburg, PA 17120 within 15 days after publication of this notice in the Pennsylvania Bulletin.
M. DIANE KOKEN,
Insurance Commissioner
[Pa.B. Doc. No. 04-1090. Filed for public inspection June 18, 2004, 9:00 a.m.]
No part of the information on this site may be reproduced for profit or sold for profit.This material has been drawn directly from the official Pennsylvania Bulletin full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.